Control of myeloid differentiation and survival by Stats.
about
Evolution of JAK-STAT pathway components: mechanisms and role in immune system developmentRequirement of STAT3 activation for differentiation of mucosal stratified squamous epithelium.Growth factors can influence cell growth and survival through effects on glucose metabolismSignal Transducers and Activators of Transcription (STAT) Regulatory Networks in Marine Organisms: From Physiological Observations towards Marine Drug DiscoveryA plant-derived remedy for repair of infarcted heartPhosphotyrosyl peptides block Stat3-mediated DNA binding activity, gene regulation, and cell transformationMultifaceted intervention by the Hsp90 inhibitor ganetespib (STA-9090) in cancer cells with activated JAK/STAT signalingActivation of STAT3 by the Src family kinase Hck requires a functional SH3 domain.Phase I study of OPB-51602, an oral inhibitor of signal transducer and activator of transcription 3, in patients with relapsed/refractory hematological malignancies.Loss of Jak2 selectively suppresses DC-mediated innate immune response and protects mice from lethal dose of LPS-induced septic shock.Systemic levels of G-CSF and interleukin-6 determine the angiogenic potential of bone marrow resident monocytes.Inhibiting signal transducer and activator of transcription 3: rationality and rationale design of inhibitors.STAT proteins: novel molecular targets for cancer drug discovery.Stat1 activation attenuates IL-6 induced Stat3 activity but does not alter apoptosis sensitivity in multiple myeloma.Inhibition of STAT3 signaling targets both tumor-initiating and differentiated cell populations in prostate cancer.Neovascularization of ischemic myocardium by newly isolated tannins prevents cardiomyocyte apoptosis and improves cardiac functionArtesunate suppresses tumor growth and induces apoptosis through the modulation of multiple oncogenic cascades in a chronic myeloid leukemia xenograft mouse model.The Immunohistochemical Expression of STAT3, Bcl-xL, and MMP-2 Proteins in Colon Adenoma and Adenocarcinoma.STAT proteins as novel targets for cancer drug discovery.Signal transducer and activator of transcription 5b (Stat5b) serine 193 is a novel cytokine-induced phospho-regulatory site that is constitutively activated in primary hematopoietic malignancies.Constitutive activation of Stat3 signaling pathway in human colorectal carcinoma.Cytokine signals through STAT3 promote expression of granulocyte secondary granule proteins in 32D cellsSignal transduction pathways that contribute to myeloid differentiation.Early gene expression of acute myeloid leukemia in response to chemotherapy.STAT3 modulates cigarette smoke-induced inflammation and protease expressionSTAT3 mutations identified in human hematologic neoplasms induce myeloid malignancies in a mouse bone marrow transplantation model.Effects of dasatinib on SRC kinase activity and downstream intracellular signaling in primitive chronic myelogenous leukemia hematopoietic cellsSprouty1 induces a senescence-associated secretory phenotype by regulating NFκB activity: implications for tumorigenesis.STAT3 regulation of glioblastoma pathogenesis.Therapeutic potential of Janus-activated kinase-2 inhibitors for the management of myelofibrosisCross-talk between tumor and myeloid cells: how to tip the balance in favor of antitumor immunity.STAT transcription factors in hematopoiesis and leukemogenesis: opportunities for therapeutic intervention.A novel platinum compound inhibits constitutive Stat3 signaling and induces cell cycle arrest and apoptosis of malignant cells.Functional characterization, localization, and inhibitor sensitivity of the TPR-FGFR1 fusion in 8p11 myeloproliferative syndrome.Prolonged classical NF-kappaB activation prevents autophagy upon E. coli stimulation in vitro: a potential resolving mechanism of inflammationThe efficiency of silencing expression of the gene coding STAT3 transcriptional factor and susceptibility of bladder cancer cells to apoptosis.Glioblastoma-induced inhibition of Langerhans cell differentiation from CD34(+) precursors is mediated by IL-6 but unaffected by JAK2/STAT3 inhibition.PRL-2 increases Epo and IL-3 responses in hematopoietic cellsCell confluence-induced activation of signal transducer and activator of transcription-3 (Stat3) triggers epithelial dome formation via augmentation of sodium hydrogen exchanger-3 (NHE3) expression.Tyrosine 729 of the G-CSF receptor controls the duration of receptor signaling: involvement of SOCS3 and SOCS1.
P2860
Q21134741-B8D4B719-27D8-4E40-80FA-80233385D27DQ22305869-B345474D-86C4-4F05-98C7-F9FA8B0CED1BQ24550867-05108EBB-C8C5-48BB-929A-67D9FA0CD497Q26799332-6E4041AD-2529-4DAA-8F9C-037F7FC1CE4BQ28474773-D243FF1C-9A14-4706-8FF6-1FD951D79C04Q28593921-B16828F4-FA07-43FB-9E06-88CBD6314C1DQ28741023-9B218F49-0B5F-4B4E-AB4F-133178DDEF26Q30165193-E5A1E5F6-4323-48C8-81AF-CBCB87E4171AQ33422320-714F2556-2945-4EAE-BAAC-98F8F8E002DFQ33541021-42AEBEA3-3E8B-4ADC-9029-071284A41680Q33942523-6C5E6AE6-EDA3-4550-B68B-CBD017E878DFQ33959754-425C3F8A-6295-4C40-95D2-EDEF74FB8360Q34293579-E37EFE32-3FD5-4F2B-8526-72D96917FFCFQ34354073-C5FB49BC-63DF-4349-85D9-3BBE567C47E6Q34483617-BC77BEFB-C17C-4779-AB5D-6A38A6C8ADC8Q34611563-23344477-1DC1-4DFD-A3A8-815499715464Q35551934-68A9ED9B-AD26-4593-A8E4-D1FBB47354F7Q35778326-1AA09E7A-F786-4726-B3D8-C9F13C40104AQ35911116-3720E2C2-EE5E-4251-83BA-1C24B0BE1242Q35956625-0E36F82D-DCE5-4CEC-B52E-8D1DFCC48FD3Q36067474-D5A665B2-8B02-4051-8D8C-E04A060ADF9DQ36664584-A41E5425-BB13-49E9-BC96-2E6E75820D8AQ36795284-87B5ECED-73E6-4AA6-96A9-811057F7D7B3Q36817144-1BA7B7B4-95D7-4321-AD2A-425CA243422AQ37208237-73D36062-9C49-4B5E-97C3-1CC0371B59CCQ37273194-5D8C1C01-757F-4BE1-9283-A4BFD213D976Q37450433-8120E074-F6FB-424F-9954-0EE61836E03DQ37475506-553324CC-5AF2-4B2A-A800-21EDD7D65A17Q37550760-4190AC7A-16E8-4662-A204-CC9180C09F97Q37705695-2A8ACF76-FB31-46D6-88FC-5C9B1CEA1508Q37822746-193C69D7-430F-4132-99D2-75779C0C959EQ38116768-2A2D0EE9-B3E3-4F6C-A16A-1639399A0385Q38323134-1A5DC6D6-4A41-49F4-88E7-CBD21F62CD47Q38833773-3C359936-8B4E-42AF-8A82-B230847CF55AQ39222665-CFB118D1-852C-408B-9A6D-466203504D65Q39420094-4DD17C03-7572-4CCC-B0D1-ABE72D19F793Q39474593-EB7F5902-25E4-49FA-9DD1-E435C742337FQ39728196-E7B690C9-6636-42D4-BA34-417321FC6DC7Q40174832-80C0E154-AD7A-4CE7-A29D-F99F516C57CDQ40395394-4278E1ED-7484-4E57-8E8E-7BE876D46C2C
P2860
Control of myeloid differentiation and survival by Stats.
description
2000 nî lūn-bûn
@nan
2000 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Control of myeloid differentiation and survival by Stats.
@ast
Control of myeloid differentiation and survival by Stats.
@en
type
label
Control of myeloid differentiation and survival by Stats.
@ast
Control of myeloid differentiation and survival by Stats.
@en
prefLabel
Control of myeloid differentiation and survival by Stats.
@ast
Control of myeloid differentiation and survival by Stats.
@en
P2093
P2860
P356
P1433
P1476
Control of myeloid differentiation and survival by Stats.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.ONC.1203477
P407
P577
2000-05-01T00:00:00Z
P5875
P6179
1046986302